company background image
688621 logo

Beijing Sun-Novo Pharmaceutical Research SHSE:688621 Stock Report

Last Price

CN¥30.70

Market Cap

CN¥3.4b

7D

-9.0%

1Y

-45.7%

Updated

08 Sep, 2024

Data

Company Financials +

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

SHSE:688621 Stock Report

Market Cap: CN¥3.4b

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Sun-Novo Pharmaceutical Research
Historical stock prices
Current Share PriceCN¥30.70
52 Week HighCN¥75.78
52 Week LowCN¥30.03
Beta0.012
11 Month Change-19.17%
3 Month Change-37.40%
1 Year Change-45.66%
33 Year Change-60.57%
5 Year Changen/a
Change since IPO-64.21%

Recent News & Updates

Concerns Surrounding Beijing Sun-Novo Pharmaceutical Research's (SHSE:688621) Performance

Sep 05
Concerns Surrounding Beijing Sun-Novo Pharmaceutical Research's (SHSE:688621) Performance

Market Still Lacking Some Conviction On Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621)

Jul 31
Market Still Lacking Some Conviction On Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621)

We Think Beijing Sun-Novo Pharmaceutical Research (SHSE:688621) Can Stay On Top Of Its Debt

May 29
We Think Beijing Sun-Novo Pharmaceutical Research (SHSE:688621) Can Stay On Top Of Its Debt

Recent updates

Concerns Surrounding Beijing Sun-Novo Pharmaceutical Research's (SHSE:688621) Performance

Sep 05
Concerns Surrounding Beijing Sun-Novo Pharmaceutical Research's (SHSE:688621) Performance

Market Still Lacking Some Conviction On Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621)

Jul 31
Market Still Lacking Some Conviction On Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621)

We Think Beijing Sun-Novo Pharmaceutical Research (SHSE:688621) Can Stay On Top Of Its Debt

May 29
We Think Beijing Sun-Novo Pharmaceutical Research (SHSE:688621) Can Stay On Top Of Its Debt

Shareholder Returns

688621CN Life SciencesCN Market
7D-9.0%-2.7%-2.4%
1Y-45.7%-41.4%-20.1%

Return vs Industry: 688621 underperformed the CN Life Sciences industry which returned -41.4% over the past year.

Return vs Market: 688621 underperformed the CN Market which returned -20.1% over the past year.

Price Volatility

Is 688621's price volatile compared to industry and market?
688621 volatility
688621 Average Weekly Movement7.5%
Life Sciences Industry Average Movement6.3%
Market Average Movement5.4%
10% most volatile stocks in CN Market8.6%
10% least volatile stocks in CN Market3.6%

Stable Share Price: 688621's share price has been volatile over the past 3 months.

Volatility Over Time: 688621's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20091,370Yujing Liuwww.sun-novo.com

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Fundamentals Summary

How do Beijing Sun-Novo Pharmaceutical Research's earnings and revenue compare to its market cap?
688621 fundamental statistics
Market capCN¥3.44b
Earnings (TTM)CN¥215.33m
Revenue (TTM)CN¥1.03b

16.0x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688621 income statement (TTM)
RevenueCN¥1.03b
Cost of RevenueCN¥452.92m
Gross ProfitCN¥581.02m
Other ExpensesCN¥365.68m
EarningsCN¥215.33m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.92
Gross Margin56.19%
Net Profit Margin20.83%
Debt/Equity Ratio41.1%

How did 688621 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

9%

Payout Ratio